
Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report) – Analysts at DOWLING & PARTN issued their FY2026 earnings estimates for Palomar in a research note issued to investors on Wednesday, May 20th. DOWLING & PARTN analyst N. Iacoviello forecasts that the company will post earnings of $8.53 per share for the year. The consensus estimate for Palomar’s current full-year earnings is $9.02 per share. DOWLING & PARTN also issued estimates for Palomar’s FY2027 earnings at $9.82 EPS.
Other equities analysts also recently issued research reports about the stock. Zacks Research downgraded shares of Palomar from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 15th. JPMorgan Chase & Co. reduced their price objective on shares of Palomar from $160.00 to $150.00 and set an “overweight” rating for the company in a research note on Tuesday. Wall Street Zen downgraded shares of Palomar from a “buy” rating to a “hold” rating in a research note on Sunday, March 1st. Weiss Ratings downgraded shares of Palomar from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. Finally, Evercore initiated coverage on shares of Palomar in a research note on Monday, February 9th. They issued an “outperform” rating and a $150.00 price objective for the company. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $147.75.
Palomar Stock Performance
Shares of NASDAQ:PLMR opened at $109.45 on Thursday. The company has a market capitalization of $2.90 billion, a price-to-earnings ratio of 15.24 and a beta of 0.49. Palomar has a 52 week low of $107.51 and a 52 week high of $175.85. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31. The firm has a 50 day moving average of $120.21 and a 200 day moving average of $124.47.
Palomar (NASDAQ:PLMR – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 EPS for the quarter, topping analysts’ consensus estimates of $2.17 by $0.14. The company had revenue of $278.94 million during the quarter, compared to the consensus estimate of $557.79 million. Palomar had a net margin of 20.11% and a return on equity of 22.62%. Palomar’s revenue for the quarter was up 59.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.87 earnings per share.
Hedge Funds Weigh In On Palomar
Large investors have recently made changes to their positions in the business. Geneos Wealth Management Inc. acquired a new position in shares of Palomar during the fourth quarter worth $32,000. Kestra Advisory Services LLC purchased a new stake in shares of Palomar during the fourth quarter valued at $33,000. Rockefeller Capital Management L.P. grew its holdings in shares of Palomar by 81.5% during the fourth quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock valued at $40,000 after buying an additional 132 shares during the last quarter. Clearstead Advisors LLC grew its holdings in shares of Palomar by 31.0% during the third quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock valued at $46,000 after buying an additional 94 shares during the last quarter. Finally, Parallel Advisors LLC grew its holdings in shares of Palomar by 638.3% during the first quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock valued at $53,000 after buying an additional 383 shares during the last quarter. 90.25% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, CEO Mac Armstrong sold 3,500 shares of the company’s stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $120.58, for a total transaction of $422,030.00. Following the transaction, the chief executive officer directly owned 339,888 shares of the company’s stock, valued at approximately $40,983,695.04. This represents a 1.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Jon Christianson sold 3,000 shares of the company’s stock in a transaction on Tuesday, April 7th. The stock was sold at an average price of $125.00, for a total value of $375,000.00. Following the transaction, the president directly owned 62,919 shares in the company, valued at approximately $7,864,875. The trade was a 4.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 18,634 shares of company stock worth $2,318,111. Insiders own 3.70% of the company’s stock.
Palomar Company Profile
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Further Reading
- Five stocks we like better than Palomar
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
